Format

Send to

Choose Destination
Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S86-8.

Novel therapies for hepatitis C virus based on lessons from virology.

Author information

1
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA 94305-5187, USA. jeffrey.glenn@stanford.edu

Abstract

As we improve our understanding of the molecular virology of hepatitis C virus (HCV), a variety of new potential antiviral strategies are emerging. Moving beyond interferon and ribavirin, these new strategies for the first time are aimed at HCV-specific targets. It is expected, by analogy with other infections, that effective pharmacologic control of HCV will be achieved best by using a cocktail of such virus-specific agents, each designed against an independent target. As a result, the way we treat HCV should change dramatically over the next few years.

PMID:
16234068
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center